Predict your next investment

Venture Capital
longitudecapital.com

See what CB Insights has to offer

Investments

126

Portfolio Exits

31

Funds

5

Service Providers

1

About Longitude Capital

Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. The Firm's growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile and attractive expected returns within three to five years from initial investment. Additionally, Longitude Capital utilizes a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties and other equity and equity-linked instruments.

Longitude Capital Headquarters Location

800 El Camino Real Suite 220

Menlo Park, California, 94025,

United States

650-854-5700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Longitude Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Longitude Capital in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

Latest Longitude Capital News

IntelyCare Secures USD 115M Series C

Apr 7, 2022

IntelyCare, a Quincy, Mass.-based tech-enabled nurse staffing platform for healthcare organizations, secured USD 115m in Series C financing. The round, which valued IntelyCare at USD 1.1 billion, was led by Janus Henderson Investors with participation from Longitude Capital, Leeds Illuminate, Endeavour Vision, Revelation Partners, and Kaiser Permanente Ventures.

Longitude Capital Investments

126 Investments

Longitude Capital has made 126 investments. Their latest investment was in IntelyCare as part of their Series C on April 4, 2022.

CBI Logo

Longitude Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/6/2022

Series C

IntelyCare

$115M

Yes

4

4/5/2022

Series D

LimFlow

$40M

Yes

2

3/15/2022

Series A

On Belay Health Solutions

$6.54M

Yes

1

2/23/2022

Series E

Subscribe to see more

$99M

Subscribe to see more

10

2/18/2022

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/6/2022

4/5/2022

3/15/2022

2/23/2022

2/18/2022

Round

Series C

Series D

Series A

Series E

Series D

Company

IntelyCare

LimFlow

On Belay Health Solutions

Subscribe to see more

Subscribe to see more

Amount

$115M

$40M

$6.54M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

2

1

10

10

Longitude Capital Portfolio Exits

31 Portfolio Exits

Longitude Capital has 31 portfolio exits. Their latest portfolio exit was Amunix on December 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/21/2021

Acquired

$99M

10

10/7/2021

IPO

$99M

Public

11

7/30/2021

IPO

$99M

Public

2

7/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/14/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/21/2021

10/7/2021

7/30/2021

7/16/2021

5/14/2021

Exit

Acquired

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

10

11

2

10

10

Longitude Capital Acquisitions

2 Acquisitions

Longitude Capital acquired 2 companies. Their latest acquisition was Ajax Vascular on November 26, 2014.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/26/2014

Series A

$99M

$1.5M

Asset Sale

8/20/2014

Debt

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/26/2014

8/20/2014

Investment Stage

Series A

Debt

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$1.5M

Note

Asset Sale

Subscribe to see more

Sources

10

Longitude Capital Fund History

5 Fund Histories

Longitude Capital has 5 funds, including Longitude Capital Prime Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/20/2021

Longitude Capital Prime Fund I

$135M

1

9/23/2020

Longitude Venture Partners IV

$99M

10

6/7/2016

Longitude Venture Partners III

Subscribe to see more

Subscribe to see more

$99M

10

10/22/2012

Longitude Venture Partners II

Subscribe to see more

Subscribe to see more

$99M

10

6/16/2008

Longitude Venture Partners

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/20/2021

9/23/2020

6/7/2016

10/22/2012

6/16/2008

Fund

Longitude Capital Prime Fund I

Longitude Venture Partners IV

Longitude Venture Partners III

Longitude Venture Partners II

Longitude Venture Partners

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$135M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Longitude Capital Service Providers

1 Service Provider

Longitude Capital has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

Longitude Capital Team

13 Team Members

Longitude Capital has 13 team members, including current Founder, Managing Director, Juliet Tammenoms Bakker.

Name

Work History

Title

Status

Juliet Tammenoms Bakker

Pequot Capital Mangement

Founder, Managing Director

Current

David J. Hirsch

Pequot Capital Mangement, and McKinsey & Company

Founder, Managing Director

Current

Sandip Agarwala

Managing Director

Current

Patrick Enright

Pequot Capital Mangement

Managing Director

Current

Doug Foster

Managing Director

Current

Name

Juliet Tammenoms Bakker

David J. Hirsch

Sandip Agarwala

Patrick Enright

Doug Foster

Work History

Pequot Capital Mangement

Pequot Capital Mangement, and McKinsey & Company

Pequot Capital Mangement

Title

Founder, Managing Director

Founder, Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.